4-Chloro-5,6-dihydro-5,6-di(piperidin-1-yl)acetyldibenzo[b,f][1,4,5]thiadiazepine

ID: ALA3265400

Chembl Id: CHEMBL3265400

PubChem CID: 46219782

Max Phase: Preclinical

Molecular Formula: C26H31ClN4O2S

Molecular Weight: 499.08

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(CN1CCCCC1)n1c2ccccc2sc2cccc(Cl)c2n1C(=O)CN1CCCCC1

Standard InChI:  InChI=1S/C26H31ClN4O2S/c27-20-10-9-13-23-26(20)31(25(33)19-29-16-7-2-8-17-29)30(21-11-3-4-12-22(21)34-23)24(32)18-28-14-5-1-6-15-28/h3-4,9-13H,1-2,5-8,14-19H2

Standard InChI Key:  BQXXYMRLOQZJAJ-UHFFFAOYSA-N

Associated Targets(Human)

SH-SY5Y (11521 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

ACHE Acetylcholinesterase (1035 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Cholinesterase (8742 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 499.08Molecular Weight (Monoisotopic): 498.1856AlogP: 5.69#Rotatable Bonds: 4
Polar Surface Area: 50.48Molecular Species: NEUTRALHBA: 7HBD:
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 6.69CX LogP: 4.56CX LogD: 4.48
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.46Np Likeness Score: -1.13

References

1. González-Muñoz GC, Arce MP, Pérez C, Romero A, Villarroya M, López MG, Conde S, Rodríguez-Franco MI..  (2014)  Dibenzo[1,4,5]thiadiazepine: a hardly-known heterocyclic system with neuroprotective properties of potential usefulness in the treatment of neurodegenerative diseases.,  81  [PMID:24858540] [10.1016/j.ejmech.2014.04.075]

Source